Stage IVB Uterine Corpus Cancer

8 clinical trials · Condition

Record	Firm	Date
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners (NCT03112668)	Rutgers, The State University of New Jersey	2017-12-06
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer (NCT02112552)	Albert Einstein College of Medicine	2014-04-10
Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors (NCT02575872)	Albert Einstein College of Medicine	2013-10-01
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820)	Roswell Park Cancer Institute	2012-03-01
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (NCT01010126)	National Cancer Institute (NCI)	2009-09-08
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer (NCT01041027)	Albert Einstein College of Medicine	2009-01-16
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (NCT00729586)	National Cancer Institute (NCI)	2008-09-01
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer (NCT00575952)	Gynecologic Oncology Group	2008-01-17

Every clearance here is in the API, with alerts when new ones post.